Na Ryung Choi

Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis

Na Ryung Choi, Ju Yeon Kim, Ji Hoon Hong et al. · BMC Gastroenterology · 2022 · 30 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection

Jihye Kim, Ju Yeon Kim, Jeong‐Hoon Lee et al. · Journal of Nuclear Medicine · 2021 · 24 citations · Full text

Medicine, Oncology, Surgery +15

Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study

Minseok Albert Kim, Heejoon Jang, Na Ryung Choi et al. · Journal of Hepatocellular Carcinoma · 2021 · 23 citations · Full text

Medicine, Oncology, Surgery +13

AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B

Hyun‐Jae Shin, Moon Haeng Hur, Byeong Geun Song et al. · Journal of Hepatology · 2024 · 21 citations

Medicine, Oncology, Radiology +16

Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation

Min Kyung Park, Yun Bin Lee, Hyemi Moon et al. · Digestive Diseases and Sciences · 2022 · 14 citations

Medicine, Oncology, Pharmacology +15